NCT06004544 Prospective Pakistan Registry of Echocardiographic Screening in Asymptomatic Pregnant Women
| NCT ID | NCT06004544 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Institute of Cardiovascular Diseases, Pakistan |
| Condition | Cardiovascular Diseases in Pregnancy |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2023-02-06 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2023-02-06 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Consecutive obstetric patients attending routine antenatal visits were enrolled in this ongoing registry. A standardized 2D transthoracic echocardiogram (TTE) protocol was employed. Ejection fraction (EF) was quantified using biplane Simpson's method.
Eligibility Criteria
Inclusion Criteria: * Obstetric patients attending routine antenatal visits Exclusion Criteria: * Patients refused to give consent for echocardiography or participation in the study
Contact & Investigator
Sabha Bhatti, MD
PRINCIPAL INVESTIGATOR
National Institute of Cardiovascular Diseases
Frequently Asked Questions
Who can join the NCT06004544 clinical trial?
This trial is open to female participants only, studying Cardiovascular Diseases in Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06004544 currently recruiting?
Yes, NCT06004544 is actively recruiting participants. Contact the research team at drsabhabhatti@gmail.com for enrollment information.
Where is the NCT06004544 trial being conducted?
This trial is being conducted at Karachi, Pakistan.
Who is sponsoring the NCT06004544 clinical trial?
NCT06004544 is sponsored by National Institute of Cardiovascular Diseases, Pakistan. The principal investigator is Sabha Bhatti, MD at National Institute of Cardiovascular Diseases. The trial plans to enroll 10,000 participants.